Análisis conceptual de las flexibilidades del sistema de patentes
DOI:
https://doi.org/10.5347/62/2025/752Keywords:
Flexibilities, TRIPS agreement, pharmaceutical patents, exceptionsAbstract
Conceptual Analysis of Patent System Flexibilities
Because of their high prices, patented drugs are becoming increasingly difficult to acquire by individuals and health budgets. Faced with this access problem, flexibilities of the patent system are commonly cited as a plausible legal tool to be used, especially by developing countries.Two aspects of these flexibilities are usually highlighted. On the one hand, they comprise a set of mechanisms (such as compulsory licenses, parallel imports or the definition of patenting requirements) aimed at tempering the outcomes of patent law in various ways. On the other hand, there is also the common idea that it is the national member states of the World Trade Organization who should define the requirements entailed by each mechanism. However, in addition to these features, it is not sufficiently clear what else they have in common and what distinguishes each mechanism.The paper shows the advantage of carrying out a theoretical-conceptual analysis of the flexibilities of the patent system by understanding most of them as exceptions of the enforcement of rights. The paper provides a conceptual framework based on a specific understanding of patent rights and the analysis of norms that give a greater clarity to a topic that has been under-theorized.
References
Andrade, Marcos, 2020: “Sistema de restricción de derechos”, en Fernando Muñoz y Viviana Ponce (eds.), Conceptos para una nueva constitución, Chile, Ediciones DER, pp.173-192.
Angell, Marcia, 2006: La verdad acerca de la industria farmacéutica. Cómo nos engaña y qué hacer al respecto, Traducción de Luz Freire, Bogotá, Grupo Editorial Norma.
Bartels, Lorand, y Paddeu, Federica (eds.), 2020: Exceptions in International Law, Oxford, Oxford University Press.
Correa, Carlos, 2002: Repercusiones de la Declaración de Doha relativa al Acuerdo sobre los ADPIC y la Salud Pública, Organización Mundial de la Salud, Departamento de Medicamentos Esenciales y Política Farmacéutica.
____________, 2003: “Intellectual Property Rights and the Protection of Public Health in Developing Countries”, The World Bank Legal Review. Law and Justice for Development, vol. 1, pp. 161-206. Disponible en: http://vlex.com/vid/462619 [Fecha de consulta: 10.12.2022].
____________, 2015: Pautas para el Examen de las Solicitudes de Patentes Farmacéuticas: Examen de las Patentes desde la perspectiva de la Salud Pública. Programa de Desarrollo de Naciones Unidas. Disponible en: https://ipaccessmeds.southcentre.int/wp-content/uploads/2019/07/UNDP-guidelines-ESP.pdf [Fecha de consulta: 04.10.2022].
Correa, Carlos, y Hilty, Reto, 2021 (eds.): Access to Medicines and Vaccines. Implementing Flexibilities Under Intellectual Property Law, Switzerland: Springer.
Costa, Gabriela, Fovaça, Marcela y Reis, Renata, 2008: “Acceso a medicamentos y propiedad intelectual en Brasil: reflexiones y estrategias de la sociedad civil”, en Revista Internacional de Derechos Humanos, año 5, Nº 8, Sao Paulo, pp. 169-198.
Duarte D’Almeida, Luis, 2015: Allowing for exceptions. A theory of defenses and defeasibility in law, Oxford, Oxford University Press.
Farma Mundi, 2007: Novartis contra la India: el caso Glivec, Documento de posición Nº 1. Disponible en: http://www.farmaceuticosmundi.org/farmamundi/descargas/pdf/fm-novartis.pdf [Fecha de consulta: 20.09.2022].
Ferrer, Jordi, 2022: “La decisión probatoria”, en J. Ferrer (coord.), Manual de Razonamiento Probatorio, México DF, Suprema Corte de la Nación, pp. 399-451.
Finkelstein, Claire O., 2000: “When the rules Swallows the exceptions”, Penn Law: Legal Scholarchip Repository, vol. 19, pp. 147-175.
García Yzaguirre, Víctor, 2022: Excepciones implícitas e interpretación. Una reconstrucción analítica, Lima, Palestra.
Guastini, Riccardo, 2014: Interpretación y argumentación, Madrid, Centro de Estudios Constitucionales.
Hage, Jaap, Waltermann, Antonia y Arosemena, Gustavo, 2020: “Exceptions in International Law”, en Lorand Bartels y Federica Paddeu (eds.), Exceptions in International Law, Oxford, Oxford University Press, pp. 11-34.
Kelsen, Hans, 1969: Teoría general del derecho y del estado, Eduardo García (trad.), México, Textos Universitarios.
___________, 1998: Teoría pura del Derecho, 2a ed., Roberto Vernengo (trad.), México D.F., Porrúa.
Khor, Martin, 2014: Compulsory License and “Government Use” to Promote Access to Medicines: Some Examples. Penang: Third World Network.
Hohfeld, Wesley, 1992: Conceptos jurídicos fundamentales, México D.F., Fontamara.
Medina Amador, Juan Manuel, 2012: “Análisis de las flexibilidades contenidas en el acuerdo ADPIC a la luz de las patentes farmacéuticas”, Revista de Ciencia Jurídica, Nº 127, pp. 109-142.
Morales, Leticia, 2015: Derechos sociales constitucionales y democracia, Madrid, Marcial Pons.
Moreso, Josep Joan, y Navarro, Pablo, 1996: “Aplicabilidad y eficacia de las normas jurídicas”, Isonomía, Nº 5, pp. 119-139.
Musungu, Sisule F. y Oh, Cecilia, 2006: The Use of Flexibilities in TRIPS by Developing Countries: Can they Promote Access to Medicines?, Geneva, South Centre – WHO.
Organización Mundial de la Propiedad Intelectual (OMPI), 2024: Constraints faced by developing countries and least developed countries (LDCs) in making full use of patent flexibilities and their impacts on access to affordable especially essential medicines for public health purposes in those countries (Update of Document SCP/26/5), SCP/36/6. Disponible en: https://www.wipo.int/edocs/mdocs/scp/en/scp_36/scp_36_6.pdf https://www.wipo.int/edocs/mdocs/scp/en/scp_36/scp_36_6.pdf[fecha de consulta: 19.10.2024].
Ramírez, Karina, 2010: “Las flexibilidades del acuerdo sobre los ADPIC: las excepciones a los derechos de patentes”, Anuario de Derecho (Universidad de los Andes, Venezuela), vol. 27.
Rodríguez, Jorge, 2012: “Against Defeasibility of Legal Rules”, en Jordi Ferrer Beltran y Giovanni Battista Ratti (eds.), The Logic of Legal Requirements: Essays on Defeasibility, Oxford, Oxford University Press, pp. 89-107.
______________, 2021: Teoría Analítica del Derecho, Madrid-Barcelona-Buenos Aires, Marcial Pons.
Ross, Alf, 1963: Sobre el derecho y la justicia, Genaro R. Carrió (trad.), Buenos Aires, Editorial Universitaria de Buenos Aires.
Schauer, Frederick, 2004: Las reglas en juego. Un examen filosófico de la toma de decisiones basadas en reglas en el derecho y en la vida cotidiana, Claudina Orunesu y Jorge L. Rodríguez (trad.), Madrid-Barcelona, Marcial Pons.
Sell, Susan K., 2008: “Acuerdos de libre comercio con disposiciones ADPIC plus y acceso a medicamentos”, en Xavier Seuba (coord), Salud Pública y Patentes Farmacéuticas. Cuestiones de Economía Política y Derecho, Barcelona, Bosch Editor.
Seuba, Xavier, 2010: La protección de la salud ante la regulación internacional de los productos farmacéuticos, Madrid, Marcial Pons.
South Centre, 1997: The TRIPS Agreement: A Guide for the South: the Uruguay Round Agreement on Trade-Related Intellectual Property Rights, Switzerland, South Centre.
Susskind, Richard, 1987: Expert System in Law. A Jurisprudential inquiry, Oxford, Clarendom Press.
Tudor, Elena Cristina, 2018: “La cláusula Bolar como excepción a los derechos conferidos por una patente farmacéutica en Europa”, Revista de Estudios Europeos, Nº71, pp. 300-308.
Von Wright, Georg Henrik, 1967: Norm and Action, London, Routledgeand Kegan Paul.
Velásquez, Germán, 2015: Pautas de patentabilidad y el acceso a medicamentos, Documento de Investigación 61. Ginebra, South Centre.
Wiiliams, Glanville, 1988: “The logic of `exceptions´”, The Cambridge Law Journal, vol. 47 Nº 2, pp. 265-291
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Isonomía - Revista de teoría y filosofía del derecho
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ITAM, the publisher, has the copyright of published articles and remaining types of publications. Publications are in open access and licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. That means, among other things, that authors can freely share their articles, once published in Isonomía, on their personal web pages, Academia.edu, etc.. Between formal acceptance and online publication, authors can share the final drafts of their articles. In contrast, authors must seek permission to reproduce or reprint work, and mention, in the first footnote, "previously published in Isonomía, year, n. x, pp. xx-xx"..
